BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30830740)

  • 1. Bioactivity-HiTES Unveils Cryptic Antibiotics Encoded in Actinomycete Bacteria.
    Moon K; Xu F; Zhang C; Seyedsayamdost MR
    ACS Chem Biol; 2019 Apr; 14(4):767-774. PubMed ID: 30830740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cebulantin, a Cryptic Lanthipeptide Antibiotic Uncovered Using Bioactivity-Coupled HiTES.
    Moon K; Xu F; Seyedsayamdost MR
    Angew Chem Int Ed Engl; 2019 Apr; 58(18):5973-5977. PubMed ID: 30843641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules.
    Okada BK; Seyedsayamdost MR
    FEMS Microbiol Rev; 2017 Jan; 41(1):19-33. PubMed ID: 27576366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteria.
    Hoshino S; Onaka H; Abe I
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):363-374. PubMed ID: 30488365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptic or Silent? The Known Unknowns, Unknown Knowns, and Unknown Unknowns of Secondary Metabolism.
    Hoskisson PA; Seipke RF
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Discovery of Cryptic Metabolites with Antiproliferative Activity.
    Han EJ; Lee SR; Hoshino S; Seyedsayamdost MR
    ACS Chem Biol; 2022 Nov; 17(11):3121-3130. PubMed ID: 36228140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing regulatory networks in Actinobacteria for natural product discovery.
    Augustijn HE; Roseboom AM; Medema MH; van Wezel GP
    J Ind Microbiol Biotechnol; 2024 Jan; 51():. PubMed ID: 38569653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a Cryptic Antifungal Compound from Streptomyces albus J1074 Using High-Throughput Elicitor Screens.
    Xu F; Nazari B; Moon K; Bushin LB; Seyedsayamdost MR
    J Am Chem Soc; 2017 Jul; 139(27):9203-9212. PubMed ID: 28590725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Momomycin, an Antiproliferative Cryptic Metabolite from the Oxytetracycline Producer Streptomyces rimosus.
    Li Y; Lee SR; Han EJ; Seyedsayamdost MR
    Angew Chem Int Ed Engl; 2022 Sep; 61(39):e202208573. PubMed ID: 35903822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation and epigenetic control of silent biosynthetic pathways in actinobacteria.
    Karimian S; Farahmandzad N; Mohammadipanah F
    World J Microbiol Biotechnol; 2024 Jan; 40(2):65. PubMed ID: 38191749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetics-free method for high-throughput discovery of cryptic microbial metabolites.
    Xu F; Wu Y; Zhang C; Davis KM; Moon K; Bushin LB; Seyedsayamdost MR
    Nat Chem Biol; 2019 Feb; 15(2):161-168. PubMed ID: 30617293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cracking the regulatory code of biosynthetic gene clusters as a strategy for natural product discovery.
    Rigali S; Anderssen S; Naômé A; van Wezel GP
    Biochem Pharmacol; 2018 Jul; 153():24-34. PubMed ID: 29309762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture.
    Kim JH; Lee N; Hwang S; Kim W; Lee Y; Cho S; Palsson BO; Cho BK
    J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 33825906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Products and the Gene Cluster Revolution.
    Jensen PR
    Trends Microbiol; 2016 Dec; 24(12):968-977. PubMed ID: 27491886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput platform for the discovery of elicitors of silent bacterial gene clusters.
    Seyedsayamdost MR
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7266-71. PubMed ID: 24808135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single Biosynthetic Gene Cluster Is Responsible for the Production of Bagremycin Antibiotics and Ferroverdin Iron Chelators.
    Martinet L; Naômé A; Deflandre B; Maciejewska M; Tellatin D; Tenconi E; Smargiasso N; de Pauw E; van Wezel GP; Rigali S
    mBio; 2019 Aug; 10(4):. PubMed ID: 31409675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-guided Investigation of Antibiotic Substances produced by Allosalinactinospora lopnorensis CA15-2(T) from Lop Nor region, China.
    Huang C; Leung RK; Guo M; Tuo L; Guo L; Yew WW; Lou I; Lee SMY; Sun C
    Sci Rep; 2016 Feb; 6():20667. PubMed ID: 26864220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous expression-facilitated natural products' discovery in actinomycetes.
    Xu M; Wright GD
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):415-431. PubMed ID: 30446891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity-Independent Discovery of Secondary Metabolites Using Chemical Elicitation and Cheminformatic Inference.
    Pimentel-Elardo SM; Sørensen D; Ho L; Ziko M; Bueler SA; Lu S; Tao J; Moser A; Lee R; Agard D; Fairn G; Rubinstein JL; Shoichet BK; Nodwell JR
    ACS Chem Biol; 2015 Nov; 10(11):2616-23. PubMed ID: 26352211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endophytic actinobacteria: Diversity, secondary metabolism and mechanisms to unsilence biosynthetic gene clusters.
    Dinesh R; Srinivasan V; T E S; Anandaraj M; Srambikkal H
    Crit Rev Microbiol; 2017 Sep; 43(5):546-566. PubMed ID: 28358596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.